NCT06720779 Virtual Rehabilitation Platform for Patients With Knee Prothesis
| NCT ID | NCT06720779 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Trak Health Solutions S.L. |
| Condition | Knee Arthropathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-06-05 |
| Primary Completion | 2025-06-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-06-05 with a primary completion date of 2025-06-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to evaluate the effectiveness and usability of the Trak Rehabilitation Platform in patients who have undergone knee replacement surgery. Its main questions are whether the Trak platform combined with conventional therapy helps patients achieve optimal functionality with fewer in-person sessions compared to conventional rehabilitation alone and whether the Trak platform improves adherence to treatment, independence in daily activities, and quality of life while reducing resource consumption. Researchers will compare the use of the Trak platform combined with conventional rehabilitation to standard rehabilitation practices to determine its impact on functional outcomes, patient and provider satisfaction, and resource efficiency. Participants will: * Use the Trak Platform as part of their personalized treatment plan. * Attend face-to-face rehabilitation sessions as prescribed. * Participate in assessments to measure functionality, adherence, independence, quality of life, and resource utilization.
Eligibility Criteria
Inclusion Criteria: * Patients aged \>18 and ≤85 years. * Patients who underwent surgery for the implantation of a knee prosthesis at the Knee Unit of the Cruces University Hospital. * Patients who require on-site rehabilitation at the Cruces university hospital rehabilitation service. * Patients who have signed the Informed Consent. Exclusion Criteria: * Patients with intellectual disability or cognitive impairment. * Patients with a history of knee infection. * Patients who cannot make use of mobile applications, cell phones, tablets, laptops or e- mail and who do not have the support of a family member or caregiver to provide support to make use of these technologies. * Patients who have not signed the Informed Consent.
Contact & Investigator
RAÚL ZABALLA FERNÁNDEZ
PRINCIPAL INVESTIGATOR
Cruces University Hospital (HU Cruces)
Frequently Asked Questions
Who can join the NCT06720779 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Knee Arthropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06720779 currently recruiting?
Yes, NCT06720779 is actively recruiting participants. Contact the research team at juanfernando@trak.es for enrollment information.
Where is the NCT06720779 trial being conducted?
This trial is being conducted at Barakaldo, Spain.
Who is sponsoring the NCT06720779 clinical trial?
NCT06720779 is sponsored by Trak Health Solutions S.L.. The principal investigator is RAÚL ZABALLA FERNÁNDEZ at Cruces University Hospital (HU Cruces). The trial plans to enroll 20 participants.